A photo illustration show a syringe. Argentina was selected to test a vaccine against COVID-19, it is estimated that the clinical phases will begin in August.The University of Oxford and AstraZeneca released positive results for their COVID-19 vaccine on Monday.It follows results being released for two other vaccines — developed by Pfizer and Moderna — which are 95% effective.
The news follows recent announcements that the vaccines developed by Pfizer and Moderna were 95% effective. According to the BBC, although less effective overall, the Oxford/AstraZeneca shot is cheaper to produce and easier to store than the other two.The vaccine technology was developed by Oxford University, and its spin-out company Vaccitech. AstraZeneca signed a deal with the university in April 2020 to further develop, mass-produce, and potentially distribute the vaccine.
The vaccine candidate had a setback in September when trials were put on hold, following an "unexplained illness", reported in one of the UK trial participant. The trials re-started when regulators in the US, UK, Brazil, South Africa and Japan confirmed that it was safe to do so. in November suggesting the vaccine produced an immune response and was safe across all generations.The European Medicines Agency , the regulatory body for Europe, has already started evaluating the vaccine's lab data in a This is a breaking news story, check back for updates.
I bet these vaccines precede the pandemic itself....something stinks puuu
SkyNews says its 90% so which is which? 🤔
Dump it in the garbage this funny 70% success?!
More good news please(((
70% supposed to be good enough?
vs